Neuropeptide S receptor 1 expression in the intestine and skin--putative role in peptide hormone secretion.
Neuropeptide S receptor 1 (NPSR1) was recently found to be genetically associated with inflammatory bowel disease in addition to asthma and related traits. Epithelia of several organs express NPSR1 isoforms A and B, including the intestine and the skin, and NPSR1 appears to be upregulated in inflammation. In this study, we used cell lines and tissue samples to characterize the expression of NPSR1 and its ligand neuropeptide S (NPS) in inflammation. We used polyclonal and monoclonal antibodies to investigate the expression of NPS and NPSR1 in intestinal diseases, such as celiac disease and food allergy, and in cutaneous inflammatory disorders. We found that NPSR1-A was expressed by the enteroendocrine cells of the gut. Overall, the expression pattern of NPS was similar to its receptor suggesting an autocrine mechanism. In an NPSR1-A overexpressing cell model, stimulation with NPS resulted in a dose-dependent upregulation of glycoprotein hormone, alpha polypeptide (CGA), tachykinin 1 (TAC1), neurotensin (NTS) and galanin (GAL) encoding peptide hormones secreted by enteroendocrine cells. Because NPSR1 was also expressed in macrophages, neutrophils, and intraepithelial lymphocytes, we demonstrated that stimulation with the pro-inflammatory cytokines tumour necrosis factor alpha and interferon gamma increased NPSR1 expression in the THP-1 monocytic cells. In conclusion, similar to other neuropeptides and their receptors, NPSR1 signalling might play a dual role along the gut-brain axis. The NPS/NPSR1 pathway may participate in the regulation of the peptide hormone production in enteroendocrine cells of the small intestine.
Sundman
L
L
Department of Medical Genetics and Research Program for Molecular Medicine, University of Helsinki, Helsinki, Finland. lilli.sundman@helsinki.fi
Saarialho-Kere
U
U
Vendelin
J
J
Lindfors
K
K
Assadi
G
G
Kaukinen
K
K
Westerholm-Ormio
M
M
Savilahti
E
E
Mäki
M
M
Alenius
H
H
D'Amato
M
M
Pulkkinen
V
V
Kere
J
J
Saavalainen
P
P
D000328:Adult; D000818:Animals; D002460:Cell Line; D002648:Child; D006801:Humans; D007249:Inflammation / Q000276:immunology / Q000473:pathology; D007371:Interferon-gamma / Q000378:metabolism; D007410:Intestinal Diseases / Q000378:metabolism / Q000473:pathology; D007413:Intestinal Mucosa / Q000378:metabolism*; D007422:Intestines / Q000166:cytology; D009000:Monocytes / Q000276:immunology; D036361:Peptide Hormones / Q000378:metabolism*; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism*; D011817:Rabbits; D043562:Receptors, G-Protein-Coupled / Q000235:genetics / Q000378:metabolism*; D012867:Skin / Q000166:cytology / Q000378:metabolism*; D012871:Skin Diseases / Q000378:metabolism / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
C484532:NPSR1 protein, human; D036361:Peptide Hormones; D020033:Protein Isoforms; D043562:Receptors, G-Protein-Coupled; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma